Jane Street’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$665K Buy
34,700
+13,200
+61% +$287K ﹤0.01% 7375
2025
Q4
$473K Buy
+21,500
New +$388K ﹤0.01% 7822
2025
Q3
Sell
-26,500
Closed -$494K 11783
2025
Q2
$494K Sell
26,500
-5,200
-16% -$103K ﹤0.01% 6948
2025
Q1
$607K Sell
31,700
-72,600
-70% -$2.12M ﹤0.01% 6502
2024
Q4
$3.76M Sell
104,300
-34,500
-25% -$1.17M ﹤0.01% 3076
2024
Q3
$5.89M Sell
138,800
-18,700
-12% -$793K ﹤0.01% 2607
2024
Q2
$6.35M Buy
157,500
+86,400
+122% +$3.6M ﹤0.01% 2627
2024
Q1
$2.52M Buy
71,100
+27,700
+64% +$742K ﹤0.01% 3724
2023
Q4
$1.28M Buy
43,400
+33,200
+325% +$689K ﹤0.01% 5122
2023
Q3
$212K Buy
10,200
+1,700
+20% +$46.7K ﹤0.01% 7546
2023
Q2
$209K Sell
8,500
-91,100
-91% -$2.93M ﹤0.01% 7636
2023
Q1
$4.04M Buy
99,600
+74,400
+295% +$3.08M ﹤0.01% 2737
2022
Q4
$1.13M Sell
25,200
-13,200
-34% -$598K ﹤0.01% 4784
2022
Q3
$1.84M Sell
38,400
-42,300
-52% -$2.32M ﹤0.01% 4324
2022
Q2
$4.78M Buy
80,700
+27,700
+52% +$2.27M ﹤0.01% 2721
2022
Q1
$6.16M Sell
53,000
-34,500
-39% -$4.03M ﹤0.01% 2689
2021
Q4
$13.2M Buy
87,500
+46,300
+112% +$6.25M ﹤0.01% 1575
2021
Q3
$4.92M Sell
41,200
-49,200
-54% -$5.42M ﹤0.01% 2761
2021
Q2
$8.8M Sell
90,400
-27,500
-23% -$2.45M ﹤0.01% 1862
2021
Q1
$10.4M Sell
117,900
-113,500
-49% -$10.5M 0.01% 1513
2020
Q4
$22.1M Sell
231,400
-54,500
-19% -$5.62M 0.01% 809
2020
Q3
$32.5M Buy
285,900
+124,300
+77% +$13.1M 0.02% 549
2020
Q2
$16M Buy
161,600
+151,400
+1,484% +$12.1M 0.01% 868
2020
Q1
$656K Sell
10,200
-42,400
-81% -$2.97M ﹤0.01% 3328
2019
Q4
$3.13M Buy
52,600
+17,900
+52% +$1.1M ﹤0.01% 1474
2019
Q3
$2.05M Sell
34,700
-23,600
-40% -$1.51M ﹤0.01% 1770
2019
Q2
$3.76M Buy
58,300
+20,900
+56% +$1.35M 0.01% 1286
2019
Q1
$2.38M Buy
37,400
+32,000
+593% +$1.68M ﹤0.01% 1848
2018
Q4
$205K Buy
+5,400
New +$191K ﹤0.01% 4461

Other funds holding TNDM

Jane Street's TNDM Position: Q1 2026 in Review

Jane Street sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 209,975 shares — an estimated $4.56M sold.

Jane Street first reported a position in TNDM in Q1 2014 and held it in 28 quarters. The position peaked at $16.7M in Q2 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Jane Street reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 209,975 Tandem Diabetes Care shares in Q1 2026, an estimated $4.56M.
  • Jane Street first reported a position in Tandem Diabetes Care in Q1 2014 and held it in 28 quarters.
  • Jane Street's Tandem Diabetes Care position peaked at $16.7M in Q2 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.